EN
境外嘉宾当前位置:首页 > 邀请嘉宾 > 境外嘉宾 >

Wenyuan Shi

人物介绍
Dr. Wenyuan Shi is currently the Chief Executive Officer & Chief Science Officer of the Forsyth Institute.  Prior to this position, Dr. Shi is the chairman and professor of Oral Biology at UCLA School of Dentistry as well as the Professor of Microbiology, Immunology and Molecular Genetics at UCLA School of Medicine.  Dr. Shi has been leading multiple NIH grants to use multidisciplinary approaches to study oral microbial pathogenesis with a specific focus on microbial biofilm, inter-species interaction and signal transduction.  In addition, Dr. Shi’s laboratory is actively involved in the development of next generation of diagnostic and therapeutic tools against oral microbial infections, including instant chairside detection of oral pathogens and peptide based targeted antimicrobial therapeutics.  These translational research efforts have resulted in novel technologies that are licensed and developed by major pharmaceutical, dental and biotech companies.  Dr. Shi is also the founding scientist, chief scientific officer and chairman of the scientific advisory board of C3J Therapeutics Inc. (www.c3-jian.com).
Dr. Shi obtained his BS degree from Fudan University (Shanghai) in 1984, acquired his Ph.D degree from University of Wisconsin-Madison in 1991 and fulfilled his postdoctoral training at University of California-Berkeley during 1992-1995.  He is co-author and co-inventor of over 220 scientific articles and 40 patents and patent applications.

摘要
The Harvard-affiliated Forsyth Institute is the world first children dental hospital with special contribution to the “growth and development” concept for pedodontics and orthodontics.  It started its first orthodontics resident program in 1915.  Under Dr. Coenraad Moorrees, Forsyth conducted
Perhaps the world largest prospective growth and development twin study, providing fundamental scientific basis for today’s orthodontics.  Currently the institute is engaging the most advanced pedo-ortho clinical care program via integrating the cutting edge technologies and molecular medicine tools into dentistry.
人物介绍
Dr. Wenyuan Shi is currently the Chief Executive Officer & Chief Science Officer of the Forsyth Institute.  Prior to this position, Dr. Shi is the chairman and professor of Oral Biology at UCLA School of Dentistry as well as the Professor of Microbiology, Immunology and Molecular Genetics at UCLA School of Medicine.  Dr. Shi has been leading multiple NIH grants to use multidisciplinary approaches to study oral microbial pathogenesis with a specific focus on microbial biofilm, inter-species interaction and signal transduction.  In addition, Dr. Shi’s laboratory is actively involved in the development of next generation of diagnostic and therapeutic tools against oral microbial infections, including instant chairside detection of oral pathogens and peptide based targeted antimicrobial therapeutics.  These translational research efforts have resulted in novel technologies that are licensed and developed by major pharmaceutical, dental and biotech companies.  Dr. Shi is also the founding scientist, chief scientific officer and chairman of the scientific advisory board of C3J Therapeutics Inc. (www.c3-jian.com).
Dr. Shi obtained his BS degree from Fudan University (Shanghai) in 1984, acquired his Ph.D degree from University of Wisconsin-Madison in 1991 and fulfilled his postdoctoral training at University of California-Berkeley during 1992-1995.  He is co-author and co-inventor of over 220 scientific articles and 40 patents and patent applications.

摘要
The Harvard-affiliated Forsyth Institute is the world first children dental hospital with special contribution to the “growth and development” concept for pedodontics and orthodontics.  It started its first orthodontics resident program in 1915.  Under Dr. Coenraad Moorrees, Forsyth conducted
Perhaps the world largest prospective growth and development twin study, providing fundamental scientific basis for today’s orthodontics.  Currently the institute is engaging the most advanced pedo-ortho clinical care program via integrating the cutting edge technologies and molecular medicine tools into dentistry.
上一篇:Wei Lin
下一篇:Werner Schupp
大会概况
会议概况
组织机构
大会相关
在线注册
在线投稿
下载中心
联系我们
大会日程
邀请嘉宾
会议日程
征文通知
注册与付费
参会指南
展览信息
同期活动
常见问题
住宿与交通
CopyRight ©2019国际正畸大会 - All Right Reserverd